A Gamma Methionine-310 to Threonine Substitution and Consequent N-glycosylation at Gamma Asparagine-308 Identified in a Congenital Dysfibrinogenemia Associated with Posttraumatic Bleeding, Fibrinogen Asahi

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1989 May 1

PMID 2496144

Citations 9

Authors

K Yamazumi

K Shimura

S Terukina

N Takahashi

M Matsuda

Affiliations

Soon will be listed here.

Abstract

In an abnormal fibrinogen with severely impaired polymerization of fibrin monomers, we identified a methionine-to-threonine substitution at position 310 of the gamma chain. Furthermore, asparagine at position 308 was found to be N-glycosylated due to a newly formed consensus sequence, asparagine(308)-glycine(309)-threonine(310). The two structural defects in the mutant gamma chain may well perturb the conformation required for fibrin monomer polymerization that is specifically assigned to the D domain of fibrinogen. This alteration also seems to affect the intermolecular gamma chain cross-linking of fibrin and fibrinogen, although the amine acceptor gamma glutamine-398 was found to function normally. These functional abnormalities may well be related to posttraumatic hemorrhage as observed in a 33-yr-old man with moderate hemorrhagic diathesis related to injuries since his early adolescence. The structure of the extra carbohydrate moiety attached to asparagine-308 was found to be identical with those derived from the normal B beta and gamma chains as evidenced by HPLC.

Citing Articles

Structural changes of proteins in liver cirrhosis and consequential changes in their function.

Gligorijevic N, Minic S, Nedic O World J Gastroenterol. 2022; 28(29):3780-3792.

PMID: 36157540 PMC: 9367231. DOI: 10.3748/wjg.v28.i29.3780.

Human plasma protein N-glycosylation.

Clerc F, Reiding K, Jansen B, Kammeijer G, Bondt A, Wuhrer M Glycoconj J. 2015; 33(3):309-43.

PMID: 26555091 PMC: 4891372. DOI: 10.1007/s10719-015-9626-2.

Fibrinogen Tokushima II: a new case of congenital dysfibrinogenemia with a γ methionine-310 to threonine substitution.

Shigekiyo T, Sekimoto E, Shirakami A, Yamaguchi H, Shibata H, Ozaki S Int J Hematol. 2012; 96(3):395-7.

PMID: 22836217 DOI: 10.1007/s12185-012-1148-0.

Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones.

Lee W, Kang D, Causevic E, Herdt A, Eckman E, Eckman C J Neurosci. 2010; 30(16):5489-97.

PMID: 20410102 PMC: 3278277. DOI: 10.1523/JNEUROSCI.6383-09.2010.

Fibrinogen Yecheon: congenital dysfibrinogenemia with gamma methionine-310 to threonine substitution.

Park E, Park G, Park R, Kim H, Lee S, Cha Y J Korean Med Sci. 2009; 24(6):1203-6.

PMID: 19949684 PMC: 2775876. DOI: 10.3346/jkms.2009.24.6.1203.

References

Mosesson M, Amrani D, Menache D . Studies on the structural abnormality of fibrinogen Paris I. J Clin Invest. 1976; 57(3):782-90. PMC: 436714. DOI: 10.1172/JCI108337. View

Yoshida N, Terukina S, Okuma M, Moroi M, Aoki N, Matsuda M . Characterization of an apparently lower molecular weight gamma-chain variant in fibrinogen Kyoto I. The replacement of gamma-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin.... J Biol Chem. 1988; 263(27):13848-56. View

Olexa S, Budzynski A . Evidence for four different polymerization sites involved in human fibrin formation. Proc Natl Acad Sci U S A. 1980; 77(3):1374-8. PMC: 348497. DOI: 10.1073/pnas.77.3.1374. View

Chung D, Chan W, Davie E . Characterization of a complementary deoxyribonucleic acid coding for the gamma chain of human fibrinogen. Biochemistry. 1983; 22(13):3250-6. DOI: 10.1021/bi00282a033. View

Schwartz M, Pizzo S, Hill R, McKee P . Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. J Biol Chem. 1973; 248(4):1395-407. View

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Marder V, Shulman N, Carroll W . High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization. J Biol Chem. 1969; 244(8):2111-9. View

Gralnick H, Givelber H, SHAINOFF J, Finlayson J . Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release. J Clin Invest. 1971; 50(9):1819-30. PMC: 292107. DOI: 10.1172/JCI106673. View

Chen R, Doolittle R . - cross-linking sites in human and bovine fibrin. Biochemistry. 1971; 10(24):4487-91. DOI: 10.1021/bi00800a021. View

10.

Doellgast G . Enzyme-linked coagulation assay. III. Sensitive immunoassays for clotting factors II, VII, and X. Anal Biochem. 1987; 162(1):102-14. DOI: 10.1016/0003-2697(87)90014-5. View

11.

Timmons S, Kloczewiak M, Hawiger J . ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets. Proc Natl Acad Sci U S A. 1984; 81(15):4935-9. PMC: 391607. DOI: 10.1073/pnas.81.15.4935. View

12.

Lorand L, Chenoweth D, Gray A . Titration of the acceptor cross-linking sites in fibrin. Ann N Y Acad Sci. 1972; 202:155-71. DOI: 10.1111/j.1749-6632.1972.tb16328.x. View

13.

Doolittle R . Structural aspects of the fibrinogen to fibrin conversion. Adv Protein Chem. 1973; 27:1-109. DOI: 10.1016/s0065-3233(08)60446-5. View

14.

Kehl M, Lottspeich F, Henschen A . Analysis of human fibrinopeptides by high-performance liquid chromatography. Hoppe Seylers Z Physiol Chem. 1981; 362(12):1661-4. View

15.

Lundblad R . A rapid method for the purification of bovine thrombin and the inhibition of the purified enzyme wtih phenylmethylsulfonyl fluoride. Biochemistry. 1971; 10(13):2501-6. DOI: 10.1021/bi00789a012. View

16.

Sakata Y, Aoki N . Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. J Clin Invest. 1980; 65(2):290-7. PMC: 371366. DOI: 10.1172/JCI109671. View

17.

Townsend R, Hilliker E, Li Y, Laine R, Bell W, Lee Y . Carbohydrate structure of human fibrinogen. Use of 300-MHz 1H-NMR to characterize glycosidase-treated glycopeptides. J Biol Chem. 1982; 257(16):9704-10. View

18.

Hewick R, Hunkapiller M, HOOD L, Dreyer W . A gas-liquid solid phase peptide and protein sequenator. J Biol Chem. 1981; 256(15):7990-7. View

19.

Nieuwenhuizen W, Voskuilen M, Vermond A, Haverkate F, Hermans J . A fibrinogen fragment D (D intermediate) with calcium binding but without anticlotting properties. Biochim Biophys Acta. 1982; 707(2):190-2. DOI: 10.1016/0167-4838(82)90349-1. View

20.

Budzynski A, Marder V, Menache D, Guillin M . Defect in the gamma polypeptide chain of a congenital abnormal fibrinogen (Paris I). Nature. 1974; 252(5478):66-8. DOI: 10.1038/252066a0. View